Evidence map›Paper›PMID 38308064›Full record

ArticleEMBO reports2024

Novel role of bone morphogenetic protein 9 in innate host responses to HCMV infection.

Markus Stempel, Oliver Maier, Baxolele Mhlekude, Hal Drakesmith, Melanie M Brinkmann

Open access · diamondAbstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Markus StempelInstitute of Genetics, Technische Universität Braunschweig, Braunschweig, Germany.ORCID 0000-0002-9240-3987
Oliver MaierInstitute of Genetics, Technische Universität Braunschweig, Braunschweig, Germany.ORCID 0009-0009-0655-1405
Baxolele MhlekudeVirology and Innate Immunity Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0003-3696-2482
Hal DrakesmithMRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.ORCID 0000-0002-8503-6103
Melanie M BrinkmannInstitute of Genetics, Technische Universität Braunschweig, Braunschweig, Germany. m.brinkmann@tu-braunschweig.de.ORCID 0000-0001-5431-6527
Helmholtz Centre for Infection Research · DEJohn Radcliffe Hospital · GBTechnische Universität Braunschweig · DE

Funding

Helmholtz Association () W2/W3-090Ministry of Science and Culture, Niedersachsen SMART BIOTECS alliance between the Technische Universität Braunschweig and the Leibniz Universität HUK Medical Research Council MRC Human Immunology Unit core funding,MC_UU_12010/10
6 · The paper itself

Abstract

Herpesviruses modulate immune control to secure lifelong infection. The mechanisms Human Cytomegalovirus (HCMV) employs in this regard can reveal unanticipated aspects of cellular signaling involved in antiviral immunity. Here, we describe a novel relationship between the TGF-β family cytokine BMP9 and HCMV infection. We identify a cross-talk between BMP9-induced and IFN receptor-mediated signaling, showing that BMP9 boosts the transcriptional response to and antiviral activity of IFNβ, thereby enhancing viral restriction. We also show that BMP9 is secreted by human fibroblasts upon HCMV infection. However, HCMV infection impairs BMP9-induced enhancement of the IFNβ response, indicating that this signaling role of BMP9 is actively targeted by HCMV. Indeed, transmembrane proteins US18 and US20, which downregulate type I BMP receptors, are necessary and sufficient to cause inhibition of BMP9-mediated boosting of the antiviral response to IFNβ. HCMV lacking US18 and US20 is more sensitive to IFNβ. Thus, HCMV has a mutually antagonistic relationship with BMP9, which extends the growing body of evidence that BMP signaling is an underappreciated modulator of innate immunity in response to viral infection.

Indexed as

Growth Differentiation Factor 2Immunity, InnateCytokinesCytomegalovirusHumansSignal TransductionCytokinesGDF2 protein, humanGrowth Differentiation Factor 2BMP9Bone Morphogenetic Protein (BMP)Human Cytomegalovirus (HCMV)US18US20

Identifiers

PMID38308064
PMCPMC10933439
OpenAlexW4391486365

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.